the market?
Boston Scientific Corp.
NYSE: BSX
9.54
-0.10
(-1.04%)
| Today's Open | $9.64 |
|---|---|
| Previous Close | $9.64 |
| Daily Range | $9.51 - $9.68 |
| 52-Week Range | $4.79 - $9.75 |
| Market Cap | $12.9B |
| P/E Ratio | -2.98 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 12,105,770 |
| Average Daily Volume | 19,891,096 |
| Current FY EPS | $0.67 |
How do you think BSX
will perform against the market?
Top BSX Bull/Bear Pitches
BillZack (10.16)
Submitted
June 17, 2010
WAY OVERSOLD AND DUE FOR A GOOD RUN WITH PESSIMISM BEGINING TO ALEVIATE. GOOD PIPELINE OF PRODUCTS.
lickmyweinie (0)
Submitted
September 29, 2010
The simple truth is that competitors have superior products. The management can't dig themselves out of the hole their in. Damage form poor acquisitions and law suits have taken their toll. When ever … More
News & Commentary
The 5 Best Medical Device Stocks of 2013
The markets have hit record highs this year, but these stocks have blown away the device industry.1 Huge Opportunity for the Star Stent of the Future
Abbott Labs' Absorb stent features exciting new technology, but is this product ready for the spotlight?FDA Warns Medical Device Makers, Hospitals and Facilities to Protect Against Hackers, Malware, Cyber
FDA Warns Medical Device Makers, Hospitals and Facilities to Protect Against Hackers, Malware, CyberattacksThese Stocks Crushed the S&P 500 Last Month
Strong results for the market were nothing compared to what these stocks did.1 Heart Device Maker Doubling Down in Europe
Medtronic fortifies its position in heart valves with a regulatory victory.Sector
Healthcare
Industry
Healthcare Information Services
Boston Scientific Corp. (BSX) Description
The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation. Website: http://www.bsci.com/
More details for Boston Scientific Jobs
Boston Scientific reviews from employees
